News Archive: February 2019

Contributed by Camilla Krogh Lauritzen, Chief Patient Officer, LEO Pharma 28 February is Rare Disease Day. Hardly any surprise to anyone who is committed to changing the status quo for the millions of people affected by one or more of the 7000+ rare diseases. But then again, it may be news for many...
On 28 February 2019, people living with or affected by a rare disease, patient organizations, politicians, carers, medical professionals, researchers and industry will come together to celebrate the twelfth annual Rare Disease Day. A patient-led campaign, organizations in over 70 countries and...
Sexual intimacy challenges can be a difficult topic to talk about, even though common for people with and without chronic conditions. To get the conversation going about sex and multiple sclerosis (MS), MS International Federation (MSIF) – an IAPO member – has recently launched an...
We at IAPO are extremely delighted that the 144th Session of the WHO Executive Board (EB), deliberated on the agenda item ‘Global Action on Patient Safety’ and adopted the Executive Board Resolution ‘ Global Action on Patient Safety’ on 31 January 2019 including the...
The European Medicines Verification Organisation, an IAPO partner through the Fight the Fakes campaign launched the world’s first digital verification system covering the medicines supply chain across Europe that promises greater security against falsified medicines. The launch of the world...